Bipolar Depression and Antidepressant-Induced Mania: A Naturalistic Study
The DOI matches its Crossref record.
Abstract
BACKGROUND: The likelihood and character of antidepressant-induced mania remain important but poorly understood factors in the treatment of bipolar depression. METHOD: We examined the response to naturalistic treatment of 29 bipolar I patients who experienced a total of 79 depressive episodes. Treatment consisted primarily of mood stabilizers used alone (N = 31) or in combination with antidepressants (N = 48). Intensity of baseline mood stabilizer therapy, adequacy of added antidepressant therapy, intensity of ensuing mania or hypomania, and course of illness prior to study were measured, and selected comparisons were made between treatment groups. RESULTS: Postdepressive mood elevations (i.e., switches) that occurred during or up to 2 months after each depressive episode were present in 28% (22/79) and judged to be severely disruptive in only 10% (8/79) of episodes. Examining only the first episode per patient, a history of a greater number of past manic episodes was associated with a higher risk of switching (p < .023). Antidepressant treatment combined with mood stabilizer therapy was not associated with higher rates of postdepressive mood elevation than mood stabilizer therapy alone. At a descriptive level, subjects treated with tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs) were associated with a higher switch rate than those treated with fluoxetine; TCAs were also associated with more intense switches. CONCLUSION: The frequency and severity of postdepressive mood elevation associated with acute or continuation antidepressant therapy may be reduced by mood stabilizers. Such elevations may be more likely in patients with a strong history of mania.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Sachs, G. S., Thase, M. E., Otto, M. W., Bauer, M., Miklowitz, D., Wisniewski, S. R., Lavori, P., Lebowitz, B., Rudorfer, M., Frank, E., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00165-3 · Cited by 533
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force On Treatment Guidelines For Bipolar Disorders (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903555881 · Cited by 399
“The switch risk with older TCAs may also be suffi ciently controlled with the addition of an antimanic agent (Boerlin et al. 1998), although this cannot totally eliminate the risk of TEAS (Quitkin et al. 1981; Bottlender et al. 1998).”
BackgroundAntidepressants in bipolar disorder: the case for caution
Ghaemi, S. N., Hsu, D. J., Soldani, F., & Goodwin, F. K. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00074.x · Cited by 393
Suppes, T., Dennehy, E. B., Hirschfeld, R. M. A., Altshuler, L. L., Bowden, C. L., Calabrese, J. R., Crismon, M. L., Ketter, T. A., Sachs, G. S., Swann, A. C., et al. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0710 · Cited by 330
Antidepressant‐induced mania: an overview of current controversies
Goldberg, J. F., & Truman, C. J. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00067.x · Cited by 311
Altshuler, L., Suppes, T., Black, D., Nolen, W. A., Keck, P. E., Frye, M. A., McElroy, S., Kupka, R., Grunze, H., Walden, J., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1252 · Cited by 287
“However, the natural switch rate into mania within 8 weeks following a depression can be high (49, 50) and can lead to the incorrect conclusion that antidepressants precipitated the switch when it was actually due to the illness itself (23).”
BackgroundViktorin, A., Lichtenstein, P., Thase, M. E., Larsson, H., Lundholm, C., Magnusson, P. K. E., & Landén, M. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13111501 · Cited by 246
“(26) compared mood-stabilizer treatment to antidepressant treatment in a small number of patients and did not find any difference in manic symptoms between the groups (14, 26).”
ResultDifferential diagnosis of bipolar disorder and major depressive disorder
Hirschfeld, R. M. (2014) · Journal of Affective Disorders · doi:10.1016/s0165-0327(14)70004-7 · Cited by 234
Age Effects on Antidepressant-Induced Manic Conversion
Martin, A., Young, C., Leckman, J. F., Mukonoweshuro, C., Rosenheck, R., & Leslie, D. (2004) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.158.8.773 · Cited by 210
“001 Any 2932 (61) 29 932 (36) SSRI 2329 (49) 24 136 (29) Other 1268 (26) 9887 (12) Tricyclic 389 (8) 2638 (3) Other psychotropic drug use, No.”
The Neurobiology of the Switch Process in Bipolar Disorder: A Review
Salvadore, G., Quiroz, J. A., Machado-Vieira, R., Henter, I. D., Manji, H. K., & Zarate, C. A. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05259gre · Cited by 209
“…et al, 1991 40 8 weeks RCT DSM-IIIR mania or hypomania Altshuler et al., 1995 8 weeks Retrospective Mania within 8 weeks of the initiation of AD tx Boerlin et al., 1998 34 Within 2 months after a depressive episode Retrospective DSM-IV mania/hypomania Bottlender et al., 2001 37 None required…”
Frye, M. A., Helleman, G., McElroy, S. L., Altshuler, L. L., Black, D. O., Keck, P. E., Nolen, W. A., Kupka, R., Leverich, G. S., Grunze, H., et al. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030322 · Cited by 194
“In addition to tricyclic antidepressant liability (23), a number of demographic and clinical risk factors have been reported in small or retrospective studies, including comorbid substance abuse (24, 25), younger age (26), decreased thyroid-stimulating hormone (27), rapid cycling (10), ss genotype at the serotonin tra…”
Olfson, M., Marcus, S. C., & Shaffer, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.865 · Cited by 192
“Sixth, thestudy includednoadultsolder than64years; therefore, theresults cannotbesafelygeneralized toolderadults,whodiffer from middle-aged adults in psychiatric suicide risk factors.(30) Finally,evenamongnonelderly individuals, thecasesareonly a small and highly selected sample of total suicide attempts anddeaths.”
BackgroundGrunze, H., Kasper, S., Goodwin, G., Bowden, C., Baldwin, D., Licht, R., Vieta, E., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150612 · Cited by 185
“…especially SSRIs, the switch risk may not be much different from the natural switch risk (Peet 1994), and can be sufficiently controlled with the addition of a mood stabiliser (Boerlin et al 1998), although a mood stabiliser cannot totally eliminate it (Bottlender et al 1998; Quitkin et al 1981).”
BackgroundDivalproex in the treatment of bipolar depression: a placebo-controlled study
Davis, L. L., Bartolucci, A., & Petty, F. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.09.009 · Cited by 181
“A major challenge in the treatment of bipolar depression is the tendency for antidepressant medications, particularly tricyclic antidepressants, to precipitate episodes of mania, or to increase cycle frequency or symptom intensity (Boerlin et al., 1998; Bottlender et al., 1998; Peet, 1994).”
BackgroundAustralian and New Zealand clinical practice guidelines for the treatment of bipolar disorder
Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder (2004) · Australian and New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2004.01356.x · Cited by 90
“Mood stabiliser and antidepressant combined: A widely used alternative to a mood stabiliser on its own is concurrent use of an antidepressant, since this may enhance and speed up antidepressant efficacy and diminish the risk of switching into mania [114,115].”
BackgroundAmsterdam, J. D., & Shults, J. (2005) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000171519.64080.c9 · Cited by 76
“Current treatment recommendations for the use of antidepressants in BP II MDE are largely based upon the treatment approach to BP I MDE, which discourages the use of antidepressants due to concern over the risk of drug-induced manic switch episodes (Wehr and Goodwin, 1979; Wehr and Goodwin, 1987; Prien et al., 1994; B…”
Method
Metadata
- Authors
- Boerlin, H. L., Gitlin, M. J., Zoellner, L. A., & Hammen, C. L.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1998-07-15
- Volume
- 59
- Issue
- 7
- Pages
- 374-379
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1993342677
- Cited by
- 142
- References
- 0
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.